Harrow (HROW) Long-Term Investments (2017 - 2022)
Harrow (HROW) recorded quarterly Long-Term Investments of $2.1 million in Q3 2022, down 62.56% quarter-over-quarter from $5.6 million in Q2 2022.
Harrow (HROW) Long-Term Investments (2017 - 2022) Analysis & Trends
Harrow's Long-Term Investments history runs 6 years deep, the most recent figure standing at $2.1 million for Q3 2022.
- In Q3 2022, Long-Term Investments changed N/A year-over-year to $2.1 million; the TTM figure through Sep 2022 stood at $2.1 million (changed N/A YoY), while the FY2021 annual figure was $11.1 million, down 60.88% from the prior year.
- Long-Term Investments was $2.1 million for Q3 2022 at Harrow, down from $5.6 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $28.5 million in Q4 2020 to a low of $1.6 million in Q2 2021.
- Historically, Long-Term Investments has averaged $15.6 million across 5 years, with a median of $16.7 million in 2020.
- The sharpest annual moves came in 2019 and 2021: Long-Term Investments soared 1048.48% in 2019, then plunged 91.64% in 2021.
- A 5-year view of Long-Term Investments shows it stood at $21.4 million in 2018, then rose by 17.65% to $25.2 million in 2019, then advanced by 12.92% to $28.5 million in 2020, then sank by 60.88% to $11.1 million in 2021, then plunged by 81.16% to $2.1 million in 2022.
- The last three Long-Term Investments figures came in at $2.1 million (Q3 2022), $5.6 million (Q2 2022), and $8.2 million (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.90 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | 5.60 Mn |
| Mar 31, 2022 | 8.25 Mn |
| Dec 31, 2021 | 11.13 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Mar 31, 2021 | 25.62 Mn |
| Dec 31, 2020 | 28.46 Mn |
| Sep 30, 2020 | 27.65 Mn |
| Jun 30, 2020 | 19.08 Mn |
| Mar 31, 2020 | 14.35 Mn |
| Dec 31, 2019 | 25.20 Mn |
| Sep 30, 2019 | 22.12 Mn |
| Jun 30, 2019 | 27.65 Mn |
| Mar 31, 2019 | 28.00 Mn |
| Dec 31, 2018 | 21.42 Mn |
| Sep 30, 2018 | 5.09 Mn |
| Jun 30, 2018 | 5.22 Mn |
| Mar 31, 2018 | 2.44 Mn |
| Dec 31, 2017 | 3.51 Mn |
| Sep 30, 2017 | 4.27 Mn |